Azatadine maleate/pseudoephedrine sulfate repetabs versus placebo in the treatment of severe perennial allergic rhinitis.

Abstract	Sixty patients took part in a randomized double-blind comparison of azatadine/pseudoephedrine versus placebo for the treatment of severe perennial allergic rhinitis. After 2 weeks of therapy subjective patient appraisal as well as objective physician evaluation showed the active drug combination to have a beneficial effect (72% good to excellent improvement versus 40% for placebo) in reducing the signs and symptoms of this allergic disorder. No adverse reactions were reported.
Authors	J Zubizaretta
Journal	The Journal of international medical research (J Int Med Res) Vol. 8 Issue 6 Pg. 395-9 ( 1980) ISSN: 0300-0605 [Print] England
PMID	6108263 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References	Delayed-Action Preparations Drug Combinations Histamine H1 Antagonists Cyproheptadine azatadine Ephedrine
Topics	Adolescent Adult Aged Cyproheptadine (analogs & derivatives, therapeutic use) Delayed-Action Preparations Double-Blind Method Drug Combinations Ephedrine (therapeutic use) Female Histamine H1 Antagonists (therapeutic use) Humans Male Middle Aged Rhinitis, Allergic, Seasonal (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!